phosphofructokinase, Muscle (PFKM) (C-Term) Peptid

Details zu Produkt Nr. ABIN981620, Anbieter: Anmelden zum Anzeigen
Proteinname
  • GSD7
  • PFK-1
  • PFK1
  • PFKA
  • PFKX
  • AI131669
  • PFK-A
  • PFK-M
  • Pfk-4
  • Pfk4
  • Pfka
  • Pfkx
  • Pfk-M
  • M-PFK
  • pfkm
  • zgc:92344
  • pfk
  • phosphofructokinase, muscle
  • phosphofructokinase, muscle a
  • phosphofructokinase, muscle S homeolog
  • PFKM
  • Pfkm
  • pfkma
  • pfkm.S
Protein Region
C-Term
Spezies
Human
2
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Geblockter Antikörper anti-phosphofructokinase, Muscle (PFKM) (C-Term) Antikörper (ABIN2788704)
Sequenz RALVFQPVAE LKDQTDFEHR IPKEQWWLKL RPILKILAKY EIDLDTSDHA
Produktmerkmale This is a synthetic peptide designed for use in combination with anti-PFKM Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Reinigung Purified
Hintergrund Three phosphofructokinase isozymes exist in humans: muscle, liver and platelet. These isozymes function as subunits of the mammalian tetramer phosphofructokinase, which catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate. Tetramer composition varies depending on tissue type. This gene encodes the muscle-type isozyme. Mutations in this gene have been associated with glycogen storage disease type VII, also known as Tarui disease. Alternatively spliced transcript variants have been described.

Alias Symbols: GSD7, MGC8699, PFK-1, PFK1, PFKA, PFKX

Protein Interaction Partner: ATP6V0A4,CAV3,DYNLL1,FHL2,NOS1,PFKL,ATP6V0A4,CAV3,FHL2,HGS,SUMO1,SUMO2

Protein Size: 780
Molekulargewicht 85 kDa
Gen-ID 5213
NCBI Accession NM_000289, NP_000280
UniProt P08237
Applikationshinweise Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Rekonstitution Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration 1 mg/mL
Buffer Final peptide concentration is 1 mg/mL in PBS.
Handhabung Avoid repeated freeze-thaw cycles.
Lagerung -20 °C
Informationen zur Lagerung For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.